These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 33755810)

  • 1. Rare Breast Cancer Subtypes.
    Jenkins S; Kachur ME; Rechache K; Wells JM; Lipkowitz S
    Curr Oncol Rep; 2021 Mar; 23(5):54. PubMed ID: 33755810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare breast cancer subtypes: histological, molecular, and clinical peculiarities.
    Dieci MV; Orvieto E; Dominici M; Conte P; Guarneri V
    Oncologist; 2014 Aug; 19(8):805-13. PubMed ID: 24969162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of breast cancer histology on the relationship between ultrasound and pathology tumor size measurements.
    Pritt B; Ashikaga T; Oppenheimer RG; Weaver DL
    Mod Pathol; 2004 Aug; 17(8):905-10. PubMed ID: 15105809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.
    Zhao H
    Breast Cancer; 2021 Jan; 28(1):187-195. PubMed ID: 32812198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histology and immunophenotype of invasive lobular breast cancer. daily practice and pitfalls.
    Varga Z; Mallon E
    Breast Dis; 2008-2009; 30():15-9. PubMed ID: 19850991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine breast carcinoma: a rare but challenging entity.
    Trevisi E; La Salvia A; Daniele L; Brizzi MP; De Rosa G; Scagliotti GV; Di Maio M
    Med Oncol; 2020 Jul; 37(8):70. PubMed ID: 32712767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Histopathologic grading of breast cancer; large variation with major consequences?].
    van Dooijeweert C; Baas IO; Deckers IAG; van der Wall E; van Diest PJ
    Ned Tijdschr Geneeskd; 2021 Jan; 164():. PubMed ID: 33651508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A foundation model for clinical-grade computational pathology and rare cancers detection.
    Vorontsov E; Bozkurt A; Casson A; Shaikovski G; Zelechowski M; Severson K; Zimmermann E; Hall J; Tenenholtz N; Fusi N; Yang E; Mathieu P; van Eck A; Lee D; Viret J; Robert E; Wang YK; Kunz JD; Lee MCH; Bernhard JH; Godrich RA; Oakley G; Millar E; Hanna M; Wen H; Retamero JA; Moye WA; Yousfi R; Kanan C; Klimstra DS; Rothrock B; Liu S; Fuchs TJ
    Nat Med; 2024 Oct; 30(10):2924-2935. PubMed ID: 39039250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unusual breast cancers: useful clues to expanding the differential diagnosis.
    Harvey JA
    Radiology; 2007 Mar; 242(3):683-94. PubMed ID: 17325062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges and potential pitfalls in magnetic resonance imaging of more elusive breast carcinomas.
    Le-Petross H; Lane D
    Semin Ultrasound CT MR; 2011 Aug; 32(4):342-50. PubMed ID: 21782124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential pattern and prognostic significance of CD4+, FOXP3+ and IL-17+ tumor infiltrating lymphocytes in ductal and lobular breast cancers.
    Droeser R; Zlobec I; Kilic E; Güth U; Heberer M; Spagnoli G; Oertli D; Tapia C
    BMC Cancer; 2012 Apr; 12():134. PubMed ID: 22471961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of molecular breast cancer subtypes among Algerian women and correlation with clinical and tumor characteristics: a population-based study.
    Cherbal F; Gaceb H; Mehemmai C; Saiah I; Bakour R; Rouis AO; Boualga K; Benbrahim W; Mahfouf H
    Breast Dis; 2015; 35(2):95-102. PubMed ID: 25736840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuroendocrine tumors of the breast: Myth or reality? A systematic review].
    Cheymol C; Abramovici O; Do Cao C; Dumont A; Robin YM; El Hajbi F; Dansin E; Bonneterre J; Lauridant G
    Bull Cancer; 2018 Apr; 105(4):431-439. PubMed ID: 29567279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 15-prostaglandin dehydrogenase expression alone or in combination with ACSM1 defines a subgroup of the apocrine molecular subtype of breast carcinoma.
    Celis JE; Gromov P; Cabezón T; Moreira JM; Friis E; Jirström K; Llombart-Bosch A; Timmermans-Wielenga V; Rank F; Gromova I
    Mol Cell Proteomics; 2008 Oct; 7(10):1795-809. PubMed ID: 18632593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subtypes of Breast Cancer in Lao P.D.R.: A Study in a Limited-Resource Setting.
    Luangxay T; Virachith S; Hando K; Vilayvong S; Xaysomphet P; Arounlangsy P; Phongsavan K; Mieno MN; Honma N; Kitagawa M; Sawabe M
    Asian Pac J Cancer Prev; 2019 Feb; 20(2):589-594. PubMed ID: 30806064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Problematic breast tumors reassessed in light of novel molecular data.
    Pareja F; Weigelt B; Reis-Filho JS
    Mod Pathol; 2021 Jan; 34(Suppl 1):38-47. PubMed ID: 33024304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of GATA3 expression in invasive breast cancer: differences in histological subtypes and immunohistochemically defined molecular subtypes.
    Shaoxian T; Baohua Y; Xiaoli X; Yufan C; Xiaoyu T; Hongfen L; Rui B; Xiangjie S; Ruohong S; Wentao Y
    J Clin Pathol; 2017 Nov; 70(11):926-934. PubMed ID: 28428285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging Features and World Health Organization Classification of Rare Breast Tumors.
    Andrijauskis D; Andrejeva-Wright L
    J Breast Imaging; 2024 Sep; 6(5):547-566. PubMed ID: 39226436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of histologic grade and histologic subtype with oncotype Dx recurrence score; retrospective review of 863 breast cancer oncotype Dx results.
    Singh K; He X; Kalife ET; Ehdaivand S; Wang Y; Sung CJ
    Breast Cancer Res Treat; 2018 Feb; 168(1):29-34. PubMed ID: 29230662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive ductal carcinoma with lobular features: a comparison study to invasive ductal and invasive lobular carcinomas of the breast.
    Arps DP; Healy P; Zhao L; Kleer CG; Pang JC
    Breast Cancer Res Treat; 2013 Apr; 138(3):719-26. PubMed ID: 23535842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.